Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients.
Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy.
G
G
Visani
Hematology, Cardarelli Hospital, Napoli, Italy.
F
F
Ferrara
Hematology, Catania University, Catania, Italy.
F
F
Di Raimondo
Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy.
F
F
Loscocco
Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy.
G
G
Sparaventi
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
S
S
Paolini
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
F
F
Fuligni
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
A
A
Gazzola
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
M
M
Rossi
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
M A
MA
Laginestra
Hematology, Catania University, Catania, Italy.
M R
MR
Caraci
Hematology, Cardarelli Hospital, Napoli, Italy.
C
C
Riccardi
Institute of Biomathematics, Urbino University, Urbino, Italy.
M
M
Rocchi
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
A
A
Visani
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
S A
SA
Pileri
Hematopathology Section, Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine, Bologna, Italy.
P P
PP
Piccaluga
Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy.
A
A
Isidori
D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D000077269:Lenalidomide; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D011446:Prospective Studies; D012074:Remission Induction; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives
D003561:Cytarabine; D013792:Thalidomide; D000077269:Lenalidomide